Phase III Study of TY-9591 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (FLETEO)
Clinical trial NCT05382728 · RECRUITING
Trial details
- NCT number
- NCT05382728
- Sponsor
- TYK Medicines, Inc
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-08
- Primary completion
- 2025-05-01
- Enrollment
- 680
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.